| Product Code: ETC6013066 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Neurodegenerative Disease Treatment Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Afghanistan Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Afghanistan Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Afghanistan |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Government initiatives to improve healthcare infrastructure and access to treatments |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals |
4.3.2 High cost of neurodegenerative disease treatments |
4.3.3 Lack of comprehensive healthcare policies and guidelines for neurodegenerative diseases |
5 Afghanistan Neurodegenerative Disease Treatment Market Trends |
6 Afghanistan Neurodegenerative Disease Treatment Market, By Types |
6.1 Afghanistan Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Afghanistan Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Afghanistan Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Afghanistan Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Afghanistan Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Afghanistan Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 Afghanistan Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 Afghanistan Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 Afghanistan Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Number of healthcare facilities offering neurodegenerative disease treatments |
8.3 Patient satisfaction with access to neurodegenerative disease treatments |
9 Afghanistan Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 Afghanistan Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Afghanistan Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 Afghanistan Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 Afghanistan Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 Afghanistan Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 Afghanistan Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here